Manipal Health Enterprises Limited
All news and filings related to Manipal Health Enterprises Limited.
View all news & filings- Medium impact
Manipal Health Enterprises Utilizes IPO Proceeds for NCD Redemption
Manipal Health Enterprises has utilized IPO proceeds to fully redeem ₹5,310 crore of listed non-convertible debentures issued by its subsidiary, Manipal Hospitals Private Limited. This action aligns with the IPO's stated objectives as per the prospectus dated July 31, 2026.
Read the summary - Low impact
Manipal Health Enterprises announces 16th AGM details via newspaper publication
Manipal Health Enterprises Limited published the notice for its 16th Annual General Meeting (AGM) on September 5, 2026. The announcement, including e-voting details, appeared in Business Standard and Vishwavani. Information is also available on the company's website.
Read the summary - Low impact
Manipal Health Enterprises to hold 16th AGM on Sep 29 via VC/OAVM
Manipal Health Enterprises Limited will hold its 16th Annual General Meeting on September 29, 2026, at 11:00 a.m. via Video Conferencing. Shareholders can access the AGM notice and the FY25-26 Annual Report online. The company is facilitating communication to shareholders without registered email addresses.
Read the summary - Low impact
Manipal Health Enterprises Announces 16th AGM on Sep 29, 2026
Manipal Health Enterprises Limited will hold its 16th AGM on September 29, 2026, via VC/OAVM. The company will distribute the AGM notice and FY25-26 Annual Report electronically to registered members. Members can participate and vote remotely or during the meeting.
Read the summary - High impact
Manipal Health Q1 FY27 Revenue Surges 38% to ₹3,091 Crore; EBITDA at ₹749 Crore
Manipal Health Enterprises reported Q1 FY27 revenue of ₹3,091 crore, up 38% YoY, and EBITDA of ₹749 crore, up 26% YoY. Growth was volume-led, with inpatient volumes up 39% and OP volumes up 26%. Digital revenue contributed 23% of total revenue. Investments in technology and clinical advancements were highlighted. Sahyadri Hospitals saw 13% revenue growth.
Read the summary - Low impact
Manipal Health Enterprises: Earnings Call Audio Recording Uploaded
Manipal Health Enterprises Limited has uploaded the audio recording of its earnings call held on August 21, 2026. The recording is accessible on the company's website, providing investors with details discussed during the analyst and investor conference.
Read the summary - Low impact
Manipal Health Enterprises Ltd. Publishes Q1 FY27 Un-audited Financial Results
Manipal Health Enterprises Limited has published its un-audited financial results for the quarter ended June 30, 2026. The results were approved by the Board on August 20, 2026, and published on August 21, 2026.
Read the summary - Medium impact
Manipal Health Enterprises Board Approves Q1 FY27 Results, Appoints New Auditors, Re-appoints Directors
Manipal Health Enterprises approved Q1 FY27 results on August 20, 2026. The Board appointed Price Waterhouse Chartered Accountants LLP as Statutory Auditors for five years and re-appointed Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia as Directors. The 16th AGM is scheduled for September 29, 2026.
Read the summary - High impact
Manipal Hospitals Q1 FY27: Revenue surges 38.1% to ₹3,091 Cr, EBITDA up 26.4%
Manipal Hospitals reported Q1 FY27 revenue of ₹3,091 Cr, up 38.1% YoY. EBITDA grew 26.4% to ₹749 Cr. PAT stood at ₹243 Cr. The company noted strong patient demand and growth in high-acuity specialties. An investor conference call is scheduled for August 21, 2026.
Read the summary - High impact
Manipal Hospitals Q1 FY27 Revenue at ₹3,091 Cr, up 38.1%; EBITDA ₹749 Cr
Manipal Hospitals reported Q1 FY27 revenue of ₹3,091 crore, a 38.1% YoY increase. EBITDA grew 26.4% to ₹749 crore. Inpatient volumes rose 38.8% and outpatient volumes increased 26.0%. Occupancy improved to 65.0%. The company noted strong performance post-listing and progress in Sahyadri integration.
Read the summary - Medium impact
Manipal Health Enterprises Board Approves Q1 FY27 Results, Appoints New Auditors, and Re-appoints Directors
Manipal Health Enterprises approved Q1 FY27 results. The Board appointed Price Waterhouse Chartered Accountants LLP as Statutory Auditors for five years and re-appointed directors Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia. The 16th AGM is scheduled for September 29, 2026. Amendments to AOA regarding director nominations were also approved.
Read the summary - Medium impact
Manipal Health Enterprises Board Approves Q1 FY27 Results, Appoints New Auditors
Manipal Health Enterprises approved Q1 FY27 unaudited results. The company appointed Price Waterhouse Chartered Accountants LLP as statutory auditors for five years. Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia were re-appointed as directors. The 16th AGM is scheduled for September 29, 2026.
Read the summary - Medium impact
Manipal Health Enterprises to Acquire Kinder Women’s Hospital for ₹130 Crore
Manipal Health Enterprises will acquire Kinder Women’s Hospital in Bengaluru for ₹130 crore. The deal adds 100 beds to Manipal's network, expanding its presence in the Whitefield micro-market. The transaction is expected to conclude within 90 days, pending approvals.
Read the summary - Medium impact
Manipal Health Enterprises Acquires Kinder Women’s Hospital for ₹130 Crore
Manipal Health Enterprises will acquire Kinder Women’s Hospital and Fertility Centre for ₹130 crore. The deal, signed on August 17, 2026, includes all business operations and assets. Kinder Hospital's revenue was ₹20.75 crore as of March 31, 2026. The acquisition is expected to drive growth and is subject to approvals, with completion within 90 days.
Read the summary - Medium impact
Manipal Health Enterprises to announce Q1 FY27 results on Aug 20, earnings call on Aug 21.
Manipal Health Enterprises will announce its Q1 FY27 results on August 20, 2026. An earnings conference call is scheduled for August 21, 2026, at 11:00 AM IST to discuss the financial performance. Management including MD & CEO, CFO, and COO will be present.
Read the summary - Low impact
Manipal Health Enterprises Authorizes Key Personnel for Disclosure Decisions
Manipal Health Enterprises Limited's Board has authorized MD & CEO Dilip Jose, CFO Sameer Agarwal, COO Karthik Rajagopal, and Company Secretary Sathish K R to determine materiality and make disclosures to stock exchanges as per SEBI regulations.
Read the summary - Low impact
Manipal Health Enterprises Appoints KFin Technologies as Registrar & Share Transfer Agent
Manipal Health Enterprises Limited has appointed KFin Technologies Limited as its Registrar & Share Transfer Agent. This appointment, effective from February 13, 2025, ensures compliance with SEBI regulations.
Read the summary - Low impact
Manipal Health Enterprises Appoints Sathish K R as Compliance Officer
Manipal Health Enterprises Limited has appointed Mr. Sathish K R as Compliance Officer, effective November 25, 2025. He also serves as General Counsel and Company Secretary. Mr. Sathish K R brings over 25 years of experience in legal and compliance functions.
Read the summary - Low impact
Manipal Health Enterprises Adopts Fair Disclosure Code for UPSI
Manipal Health Enterprises Limited has adopted a Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) as per SEBI regulations. The code details procedures for uniform dissemination of UPSI and defines 'legitimate purpose' for information sharing. It will be published on the company website.
Read the summary - Low impact
Manipal Health Enterprises: Trading Window Closed from Aug 5, 2026 for Q1 FY27 Results
Manipal Health Enterprises Limited has closed its trading window from August 5, 2026. The window will reopen 48 hours after the announcement of financial results for the quarter ended June 30, 2026. Designated persons and insiders are restricted from trading company shares during this period.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio